H-D-Arg(Mtr)-OH

H-D-Arg(Mtr)-OH is a protected L-arginine derivative presented as the free carboxylic acid with an N-terminal hydrogen (H-) and a side-chain guanidinium protected as the Mtr (2-methoxy-4-methylphenylsulfonyl) group. The molecule retains the stereogenic center of arginine, providing a defined chiral amino acid scaffold for peptide coupling chemistry, while the protected guanidine reduces competing nucleophilicity during amide bond formation. The Mtr-protected side chain is engineered for orthogonal deprotection under strongly acidic conditions, enabling late-stage reveal of the guanidinium functionality for subsequent salt-formation, hydrogen-bonding interactions, or further derivatization. As an amino acid building block with a carboxylic acid handle and a protected cationic side-chain, H-D-Arg(Mtr)-OH functions as a controlled intermediate for generating arginine-containing peptides and for constructing guanidinium-bearing fragments used in biochemical and materials-oriented synthesis.

1. Peptide Synthesis

H-D-Arg(Mtr)-OH is applied in peptide building block preparation where arginine residues must be incorporated without side reactions from the guanidinium group during coupling. The amino acid structure provides a carboxylic acid for activation and an N-terminal amino functionality (H-) suitable for forming amide bonds, while the Mtr-protected guanidine suppresses undesired complexation and minimizes interference with standard peptide coupling reagents. Orthogonal deprotection of the Mtr group can be scheduled after chain assembly to regenerate the native-like guanidinium side chain for correct charge distribution in the final peptide. Downstream, the compound supports synthesis of arginine-rich sequences used in peptide chemistry, protein-mimetic studies, and peptidomimetic scaffold construction.

2. Protected Amino Acids

H-D-Arg(Mtr)-OH is utilized as a protected amino acid derivative for controlled guanidinium chemistry in synthetic organic workflows that require temporary masking of strongly basic functionalities. The Mtr group provides a protecting-group strategy that maintains the stereochemical integrity of the arginine backbone while preventing guanidinium participation in coupling, acylation, or side-chain functionalization steps. Deprotection can be integrated into multistep synthetic routes to enable sequential introduction of cationic motifs, including guanidinium-driven binding epitopes and salt-forming sites. The resulting unmasked arginine derivative can then be carried forward to generate peptide intermediates, charged fragments, or analogs for structure-based modification.

3. Bioconjugation Chemistry

H-D-Arg(Mtr)-OH is suitable for chemical biology workflows that require guanidinium-bearing handles for biomolecule recognition and conjugation strategies. The protected guanidine allows the amino acid to be incorporated into peptide linkers or functional fragments under conditions that would otherwise promote nonspecific interactions or salt-mediated aggregation. After Mtr removal, the exposed guanidinium group can participate in strong hydrogen bonding and electrostatic interactions, supporting attachment of arginine-containing motifs to proteins, peptides, or polymer backbones through amide linkage formation. The compound therefore serves as a chiral intermediate for generating conjugation-ready building blocks used in biomolecule labeling and molecular interaction studies.

4. Protein Engineering

H-D-Arg(Mtr)-OH is employed in protein engineering and protein-mimetic design where arginine side-chain charge and hydrogen-bonding patterns influence folding, binding, and recognition. The defined stereochemistry of the arginine backbone supports incorporation into peptide segments that model protein interfaces, while the Mtr-protected guanidine enables stepwise synthesis of charged residues in a controlled manner. Late-stage deprotection can be used to restore the guanidinium functionality after assembly of longer constructs, supporting accurate presentation of cationic sites for downstream functional evaluation. The compound can be applied to generate arginine-containing variants, segmental constructs, and sequence-defined materials that reflect protein-like electrostatic features.

5. Pharmaceutical Manufacturing

H-D-Arg(Mtr)-OH is relevant to pharmaceutical intermediate preparation and manufacturing-oriented peptide synthesis where robust protection of arginine side chains supports reproducible process chemistry. The amino acid ester/acid functionality (carboxylic acid) and N-terminal amino handle enable incorporation into peptide intermediates under activated coupling conditions, while the Mtr group provides a predictable masking of the guanidinium that can be removed in a controlled deprotection step. Process compatibility is supported by the orthogonal behavior of the Mtr protecting group relative to many peptide backbone and side-chain protecting groups, allowing manufacturing routes to be designed around staged deprotection and purification. The resulting arginine-containing peptide fragments can be used as feedstocks for further synthetic elaboration into drug-like peptides, peptidomimetic intermediates, and defined charged scaffolds.

1. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

3. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

4. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

5. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications